Avalon and AppliedMicro Enable Efficient 100G Muxponder Applications
Mount Pearl, NL - July 13, 2010 -- Avalon Microelectronics, a leading developer of IP for optical transport networks (OTN) today announced the development of a 100G GMP adaptation application to interface with AppliedMicro's Yahara 10G Framer/Mapper/PHY device.
Yahara 10G Framer/Mapper/PHY device maps any 10G client to a generic pODTU-24 frame at a common clock rate for efficient implementation of 100G Muxponder application. The 100G GMP adaptation approach translates information mapped to Yahara's pODTU-24 proprietary format into standard GMP mapping. The application interfaces with multiple Yahara devices to map 10G clients to a 100G line rate.
"Avalon's 100G GMP adaptation application allows Optical Equipment Manufacturers (OEMs) to take advantage of the size and power savings provided by the Yahara device to enable efficient 100G muxponder applications," said Wally Haas, Avalon's Founder and CTO.
"New standards for 100G are just emerging and OEMs are eager to implement these higher transmission speeds to meet ever growing demand," said Sandeep Gupta, Vice President and General Manager of AppliedMicro's Transport and Datacom Business Unit. "Avalon's 100G GMP adaptation allows these OEMs to develop muxponder solutions to meet this growing demand and it utilizes AppliedMicro's 10G Yahara OTN framer-mapper-PHY devices which have significant design momentum in this rapidly growing area."
This collaboration between Avalon and AppliedMicro demonstrates the commitment of both companies to develop and implement technologies in the still-emergent 100G space, and adds yet another application to Avalon's growing portfolio of leading-edge 100G solutions.
About Avalon Microelectronics:
Avalon Microelectronics is a recognized leader in the development and delivery of IP for OTN, SONET/SDH and Ethernet applications to Telecom Equipment Manufacturers. Avalon provides silicon-proven, customized IP to accelerate Time-to-Market of Next-Generation Optical Networks. For more information about Avalon Microelectronics' products and applications, please visit us at www.avalonmicro.ca or call 1(709) 747-4400.
About AppliedMicro:
AppliedMicro is a global leader in energy conscious computing solutions for telco, enterprise, data center, consumer and SMB applications. With a 30-year heritage as an innovator in high-speed connectivity and high performance embedded processing, AMCC, now AppliedMicro, employs patented transport and embedded processor SoCs to provide high performance energy efficient products. AppliedMicro's corporate headquarters are located in Sunnyvale, California. Sales and engineering offices are located throughout the world. For further information regarding AppliedMicro, visit the company's Web site at www.apm.com
|
Related News
- Avalon Microelectronics Announces Availability of 40G SONET/SDH Framer/Mapper/Pointer Processor
- Efficient and GlobalFoundries Partner to Enable a New Category of Ultra Energy-Efficient, High-Performance Processors
- Ethernovia Unveils World's First Single and Quad Port, 10G to 1G Automotive PHY in 7nm
- MIPI Alliance and Automotive SerDes Alliance Enter Liaison Agreement to Enable Native MIPI CSI-2 Implementation with ASA-ML PHY
- GOWIN Semiconductor USB 2.0 PHY Interface and Device Controller IPs Achieve USB-IF Certification
Breaking News
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- Keysom Unveils Keysom Core Explorer V1.0
Most Popular
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- Ceva, Inc. Announces First Quarter 2025 Financial Results
- Cadence Unveils Millennium M2000 Supercomputer with NVIDIA Blackwell Systems to Transform AI-Driven Silicon, Systems and Drug Design
![]() |
E-mail This Article | ![]() |
![]() |
Printer-Friendly Page |